AIM: Glioblastoma multiforme (GBM) is one of the most frequent human brain tumor and causes dismal outcome. To identify tumor-associated antigens in GBM patients may find potential diagnostic markers and immunotherapeutic targets. In this study, we identified a gene termed URGCP using the serological identification of antigens by recombinant A2B5 positive glioma cDNA library. The gene product of URGCP is immunogenic in GBM after tested in allogenic patients serum screening. METHODS AND RESULTS: GBM patients with an auto-antibody response against URGCP show longer survival than those without URGCP response. In additional, we show that URGCP was high expression in most GBM tissues and cell lines compared with normal brain tissues and majorly co-expressed with stem cell marker A2B5. CONCLUSION: We identified a potential new biomarker of GBM, URGCP. The findings indicate that URGCP is immunogenic in human GBM and suggest its potential use as diagnostic and immunotherapeutic for GBM patients.
AIM: Glioblastoma multiforme (GBM) is one of the most frequent humanbrain tumor and causes dismal outcome. To identify tumor-associated antigens in GBM patients may find potential diagnostic markers and immunotherapeutic targets. In this study, we identified a gene termed URGCP using the serological identification of antigens by recombinant A2B5 positive glioma cDNA library. The gene product of URGCP is immunogenic in GBM after tested in allogenic patients serum screening. METHODS AND RESULTS: GBM patients with an auto-antibody response against URGCP show longer survival than those without URGCP response. In additional, we show that URGCP was high expression in most GBM tissues and cell lines compared with normal brain tissues and majorly co-expressed with stem cell marker A2B5. CONCLUSION: We identified a potential new biomarker of GBM, URGCP. The findings indicate that URGCP is immunogenic in human GBM and suggest its potential use as diagnostic and immunotherapeutic for GBM patients.
Authors: N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson Journal: Neoplasia Date: 2002 Jul-Aug Impact factor: 5.715
Authors: Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich Journal: Nature Date: 2006-10-18 Impact factor: 49.962
Authors: Rudolf Schmits; Björn Cochlovius; Gerhard Treitz; Evi Regitz; Ralf Ketter; Klaus-Dieter Preuss; Bernd F M Romeike; Michael Pfreundschuh Journal: Int J Cancer Date: 2002-03-01 Impact factor: 7.396
Authors: Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff Journal: N Engl J Med Date: 2005-03-10 Impact factor: 91.245
Authors: Alfred T Ogden; Allen E Waziri; Richard A Lochhead; David Fusco; Kim Lopez; Jason A Ellis; Joann Kang; Marcela Assanah; Guy M McKhann; Michael B Sisti; Paul C McCormick; Peter Canoll; Jeffrey N Bruce Journal: Neurosurgery Date: 2008-02 Impact factor: 4.654
Authors: Andreas Mock; Rolf Warta; Christoph Geisenberger; Ralf Bischoff; Alexander Schulte; Katrin Lamszus; Volker Stadler; Thomas Felgenhauer; Christian Schichor; Christoph Schwartz; Jakob Matschke; Christine Jungk; Rezvan Ahmadi; Felix Sahm; David Capper; Rainer Glass; Jörg-Christian Tonn; Manfred Westphal; Andreas von Deimling; Andreas Unterberg; Justo Lorenzo Bermejo; Christel Herold-Mende Journal: Oncotarget Date: 2015-05-30
Authors: Yuri D Ivanov; Kristina A Malsagova; Vladimir P Popov; Igor N Kupriyanov; Tatyana O Pleshakova; Rafael A Galiullin; Vadim S Ziborov; Alexander Yu Dolgoborodov; Oleg F Petrov; Andrey V Miakonkikh; Konstantin V Rudenko; Alexander V Glukhov; Alexander Yu Smirnov; Dmitry Yu Usachev; Olga A Gadzhieva; Boris A Bashiryan; Vadim N Shimansky; Dmitry V Enikeev; Natalia V Potoldykova; Alexander I Archakov Journal: Molecules Date: 2021-06-18 Impact factor: 4.411